Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric Observational Study in Times of Health Emergency.
Saved in:
| Title: | Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric Observational Study in Times of Health Emergency. |
|---|---|
| Authors: | Ughi N; Division of Rheumatology, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, p.zza Ospedale Maggiore 3, 20162, Milan, MI, Italy. nicola.ughi@ospedaleniguarda.it., Bernasconi DP; Bicocca Bioinformatics Biostatistics and Bioimaging Centre-B4, School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy., Del Gaudio F; Functional Department for Higher Education, Research, and Development, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Dicuonzo A; Functional Department for Higher Education, Research, and Development, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Maloberti A; Division of Cardiology 4, Cardio-Thoraco-Vascular Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.; School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy., Giannattasio C; Division of Cardiology 4, Cardio-Thoraco-Vascular Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.; School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy., Tarsia P; Division of Pneumology, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Travi G; Division of Infectious Disease, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Scaglione F; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; Division of Chemical-Clinical and Microbiological Analyses, Department of Laboratory Medicine, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Colombo F; Division of Internal Medicine 1, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bertuzzi M; Division of Quality and Clinical Risk, Continuous Quality Improvement, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Adinolfi A; Division of Rheumatology, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, p.zza Ospedale Maggiore 3, 20162, Milan, MI, Italy., Valsecchi MG; Bicocca Bioinformatics Biostatistics and Bioimaging Centre-B4, School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy., Rossetti C; Functional Department for Higher Education, Research, and Development, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Functional Department for Higher Education, Research, and Development, Interhospital Functional Department of Nuclear Medicine, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Epis OM; Division of Rheumatology, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, p.zza Ospedale Maggiore 3, 20162, Milan, MI, Italy. |
| Corporate Authors: | Niguarda COVID Working Group |
| Source: | Clinical drug investigation [Clin Drug Investig] 2023 Oct; Vol. 43 (10), pp. 763-771. Date of Electronic Publication: 2023 Sep 22. |
| Publication Type: | Observational Study; Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1918 |
|---|---|
| DOI: | 10.1007/s40261-023-01304-4 |
